What is the global market size of Assisted Reproductive Technology Market?

Global Assisted Reproductive Technology Market size was valued at USD 2101.5 million in 2021 and is poised to grow from USD 2507.09 million in 2022 to USD 12272.5 million by 2030, growing at a CAGR of 19.3% in the forecast period (2023-2030).

Global Assisted Reproductive Technology Market Size, Share, Growth Analysis, By Technique(In Vitro Fertilization (IVF), Artificial Insemination (AI-IUI)), By Procedure(Fresh Donor, Fresh Non-donor), By End User(Hospitals, Fertility Clinics) - Industry Forecast 2024-2031

Report ID: SQMIG35G2228 | Region: Global | Published Date: February, 2024
Pages: 165 | Tables: 91 | Figures: 76

Global Assisted Reproductive Technology Market News

Global Assisted Reproductive Technology Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Assisted Reproductive Technology Market size was valued at USD 2101.5 million in 2019 and is poised to grow from USD 2507.09 million in 2023 to USD 12272.5 million by 2031, growing at a CAGR of 19.3% in the forecast period (2024-2031).

Key players in the global assisted reproductive technology market are implementing a variety of strategies such as such as product launches, investment in R&D, and the expansion of product portfolios in order to increase their market presence. For instance, in January 2021, CooperSurgical acquired Embryo Options a significant leader in cryo-storage software systems for reproductive clinics. Patients will benefit from the Embryo Options platform's online tools, which will provide information regarding stored specimens for future ART treatment cycles. Hamilton Throne Ltd., a global provider of ART research, for example, acquired IVFTECH ApS (IVFtech) and its subsidiary firm, K4 Technology ApS, in July 2021. With the assistance of its affiliated company, K4, IVFtech is committed to supplying laminar flow workstations and large-capacity incubators for ART. The deal was valued $8 million. 'CooperSurgical, Inc. (a subsidiary of The Cooper Companies Inc.)', 'Vitrolife AB', 'Ferring Pharmaceuticals Inc.', 'Cook Medical LLC', 'Irvine Scientific Sales Company Inc. (a subsidiary of Fujifilm Holdings Corporation)', 'Thermo Fisher Scientific Inc.', 'Merck KGaA (through its subsidiary, Merck Serono S.A.)', 'Genea Limited', 'Boston IVF', 'OvaScience Inc. (a subsidiary of Millendo Therapeutics Inc.)', 'IGENOMIX', 'Progyny Inc.', 'Bloom IVF Group', 'IVI-RMA Global', 'CryoChoice LLC', 'Cryos International – USA', 'Cryopoint LLC', 'Reproductive Medicine Associates of New Jersey', 'CARE Fertility Group', 'The Fertility Partnership'

Rising prevalence of infertility is accelerating market growth

The increased acceptance of ART in society as a result of the adoption of more advanced technologies such as Endometrial Receptivity Analysis Testing (ERA), Pre-implantation Genetic Testing (PGT), Magnetic Activated Cell Sorting (MACS), and time-lapse imaging of embryos is expected to drive demand for assisted reproductive technology procedures. According to the CDC's 2019 Reproductive Clinic Success Rates Report, roughly 330,773 assisted reproductive technology operations were performed at 448 fertility clinics in the United States, accounting for 77,998 live births and 83,946 live-born infants. Furthermore, increased awareness regarding the causes and treatment of infertility is projected to move the market forward.

Europe dominated the market in 2021, accounting for more than 37.20% of total revenue. The large percentage can be linked to an increase in the rate of infertility, improved awareness about fertility treatments, technical developments, and supportive government activities. According to the European Society of Human Reproduction and Embryology, roughly 25 million people in the European Union suffer from infertility, which is the highest rate in the world. During the predicted period, North America is expected to increase significantly. The beneficial outcomes obtained by patients undergoing treatment are linked to the growth.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Global Assisted Reproductive Technology Market Size, Share, Growth Analysis, By Technique(In Vitro Fertilization (IVF), Artificial Insemination (AI-IUI)), By Procedure(Fresh Donor, Fresh Non-donor), By End User(Hospitals, Fertility Clinics) - Industry Forecast 2024-2031

Global Assisted Reproductive Technology Market News

Global Assisted Reproductive Technology Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Assisted Reproductive Technology Market?

Who are the key vendors in the Global Assisted Reproductive Technology Market?

What is the key driver of Global Assisted Reproductive Technology Market?

What is the key market trend for Global Assisted Reproductive Technology Market?

Which region accounted for the largest share in Global Assisted Reproductive Technology Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300